mRNA COVID-19 vaccine: A future hope for cancer treatment

Authors

DOI:

https://doi.org/10.3126/jbs.v8i2.41959

Keywords:

Carcinoma, COVID-19, DNA, mRNA, nanoparticles, tumour

Abstract

Background: mRNA vaccines have a strong potential for a possible cancer therapy platform. They express tumor antigens in antigen-presenting cells (APCs) after immunization, facilitating innate/adaptive immune stimulation. Because of its high effectiveness, safe administration, rapid development potential, and cost-efficient manufacturing, the mRNA cancer vaccine surpasses other traditional vaccination platforms.

Conclusion: Careful evaluation of promising mRNA vaccines to supervise as carriers of lipids for cancer patients needs to be done. In addition, a possible revaluation for optimal protection is required. However, the extent to which solid tumours might take a significant part of the vaccine doses is still unknown. 

Downloads

Download data is not yet available.
Abstract
191
PDF
129

Author Biographies

Ajay Kumar Yadav, The Second Affiliated Hospital of Chongqing Medical University, PR China

Department of Nuclear Medicine

Suman Gnawali, BP Koirala Memorial Cancer Hospital, Bharatpur, Nepal

Technologist BMIT, Department of Radiology & Nuclear Medicine

Sandip Mandal, BP Koirala Memorial Cancer Hospital, Bharatpur, Nepal

Technologist BMIT, Department of Radiology & Nuclear Medicine

Gyan Bahadur Shrestha, BP Koirala Memorial Cancer Hospital, Bharatpur, Nepal

Senior Consultant, Department of Radiology & Nuclear Medicine

Gangbiao Yuan, The Second Affiliated Hospital of Chongqing Medical University, PR China

Professor, Department of Nuclear Medicine

Downloads

Published

2021-12-31

How to Cite

Yadav, A. K., Gnawali, S., Mandal, S., Shrestha, G. B., & Yuan, G. (2021). mRNA COVID-19 vaccine: A future hope for cancer treatment. Journal of Biomedical Sciences, 8(2), 47–49. https://doi.org/10.3126/jbs.v8i2.41959

Issue

Section

Short Communications